Compound information
- Natural Products
- ZC3408059
- Molecular Formula
- C31H26N6O4S2
- Molecular Weight
- 610.145695312 g/mol
- Structure
-
- IUPAC Name
- 1-(6-methoxy-1,3-benzothiazol-2-yl)-3-[4-[[4-[(6-methoxy-1,3-benzothiazol-2-yl)carbamoylamino]phenyl]methyl]phenyl]urea
- InChI
- InChI=1S/C31H26N6O4S2/c1-40-22-11-13-24-26(16-22)42-30(34-24)36-28(38)32-20-7-3-18(4-8-20)15-19-5-9-21(10-6-19)33-29(39)37-31-35-25-14-12-23(41-2)17-27(25)43-31/h3-14,16-17H,15H2,1-2H3,(H2,32,34,36,38)(H2,33,35,37,39)
- InChI Key
- BGSYKVXEYOUTLW-UHFFFAOYSA-N
- SMILES
- COc1ccc2nc(NC(=O)Nc3ccc(Cc4ccc(NC(=O)Nc5nc6ccc(OC)cc6s5)cc4)cc3)sc2c1
- Source
- ZINC000005648411
Warheads
- Urea carbonyl
-
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 43 | Ring Count | 6 |
Heteroatom Count | 12 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 126.5 Å2 | LogP | 6.355 |
LogS | -6.663 | LogD | 5.371 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.997 | Pgp substrate | 0.671 |
HIA | 0.953 | F20 % | 0.974 |
F30 % | 0.029 | Caco-2 | -5.132 |
MDCK | -4.81 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.001 | PPB | 96.697 |
VD | 0.701 | Fu | 2.478 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.018 | CYP1A2 substrate | 0.834 |
CYP2A6 substrate | 0.255 | CYP2B6 substrate | 0.493 |
CYP2C19 inhibitor | 0.867 | CYP2C19 substrate | 0.924 |
CYP2C8 substrate | 0.941 | CYP2C9 inhibitor | 0.382 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.773 |
CYP2D6 substrate | 0.703 | CYP2E1 substrate | 0.492 |
CYP3A4 inhibitor | 0.476 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.195 | CL | 3.993 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.033 | Hepatotoxicity | 0.998 |
Mutagenicity | 0.21 | Rat Oral Acute Toxicity | 0.001 |
FDAMDD | 0.895 | Skin Sensitization | 0.33 |
Carcinogenicity | 0.777 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.128 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.62 | IGC50 | 4.844 |
LC50FM | -6.644 | LC50DM | 4.444 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.678 | NR-AR-LBD | 0.471 |
NR-AhR | 0.999 | NR-Aromatase | 0.027 |
NR-ER | 0.883 | NR-ER-LBD | 0.722 |
NR-PPAR-gamma | 0.765 | SR-ARE | 0.953 |
SR-ATAD5 | 0.939 | SR-HSE | 0.031 |
SR-MMP | 0.98 | SR-p53 | 0.965 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.